Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...

The fourth Subject was safely treated with the low-dose of BB-301 in December 2024, and the fifth Subject was safely treated with the low-dose of BB-301 in early February 2025. The sixth Subject is ...

Japan: A recent study found that severe dysphagia in patients undergoing percutaneous endoscopic gastrostomy (PEG) was linked ...

Medically reviewed by Qin Rao, MD Pill esophagitis, or drug-induced esophagitis, occurs when oral medications cause ...

This is called dysphagia.” Another symptom ... “Going to the doctor early is important, as it can increase your chance of ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

Post-treatment, all patients exhibited satisfactory improvements ... Concurrently, she developed new symptoms including hoarseness and dysphagia, predominantly with solid foods. These clinical ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Determining who needs which type of treatment remains a significant challenge ... speech, or language; dysphagia; spasticity; mental or behavioral health; sensory rehabilitation; neglect ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...